Haematocrit and the risk of developing end-stage renal disease.
about
Hypoxia: The Force that Drives Chronic Kidney DiseasePredicting the risk of end-stage renal disease in the population-based setting: a retrospective case-control study.Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012.Epoetin therapy and hemoglobin level variability in nondialysis patients with chronic kidney diseasePerspective in chronic kidney disease: targeting hypoxia-inducible factor (HIF) as potential therapeutic approach.The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease.Impact of bone-marrow-derived mesenchymal stem cells on adriamycin-induced chronic nephropathy.Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study.Erythropoiesis-stimulating agent slows the progression of chronic kidney disease: a possibility of a direct action of erythropoietin.High Target Hemoglobin With Erythropoiesis-Stimulating Agents Has Advantages in the Renal Function of Non-Dialysis Chronic Kidney Disease Patients
P2860
Q26768865-0FE5ED85-81FB-4994-B797-85F84C470E58Q33890631-84EEAF26-6C76-49A0-9D04-039A21F7067DQ37115569-5281EB8E-50FC-4E09-A825-AB16B22C936DQ37123211-A2BDA9ED-0EB2-4779-AEC8-D8D315AE151BQ37977513-1B897F77-6B05-4553-9784-2B4F43600C45Q45324913-B2C5359B-8A0A-4F13-B946-71AAE81F8B9AQ46617533-BEF0F1A7-36BA-461B-ADEE-D6AF332B0EC5Q47167658-BAA8B0E8-D896-4B8E-A055-BA2904AF790BQ48693196-B8A17E9A-1376-47CE-BA6D-8ECAA51E3322Q57623230-D7187162-40DB-45AA-BA51-498554FE970D
P2860
Haematocrit and the risk of developing end-stage renal disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Haematocrit and the risk of developing end-stage renal disease.
@en
Haematocrit and the risk of developing end-stage renal disease.
@nl
type
label
Haematocrit and the risk of developing end-stage renal disease.
@en
Haematocrit and the risk of developing end-stage renal disease.
@nl
prefLabel
Haematocrit and the risk of developing end-stage renal disease.
@en
Haematocrit and the risk of developing end-stage renal disease.
@nl
P2093
P2860
P356
P1476
Haematocrit and the risk of developing end-stage renal disease.
@en
P2093
Chiho Iseki
Kunitoshi Iseki
Shuichi Takishita
Yoshiharu Ikemiya
P2860
P304
P356
10.1093/NDT/GFG021
P407
P577
2003-05-01T00:00:00Z